Physician factors as an indicator of technological device adoption

被引：7
作者：
Artis L.C. [1 ]
Burkhart T.M. [2 ]
Johnson T.J. [2 ]
Matuszewski K.A. [3 ]
机构：
[1] Department of Health Systems Management, Rush University, Chicago, IL
[2] Rush University Medical Center, Chicago, IL
[3] University HealthSystem Consortium, Oak Brook, IL
来源：
Journal of Medical Systems | 2006年 / 30卷 / 3期
关键词：
Adoption curve; Interventional cardiologists; Medical devices; Outcomes; Technology adoption;
D O I：
10.1007/s10916-005-8066-2
中图分类号：
学科分类号：
摘要：
This paper analyzes a sample interventional cardiologist's demographic, academic, and professional characteristics to provide an understanding of their technological device adoption styles. The study sample consisted of 15 physicians from two large Midwestern hospitals, one an academic medical center and the other a medium-sized community hospital. Interventional cardiologists were identified through their online physician profile and respective departments. A questionnaire was developed to assess each physician's self-perceived adoption style, their awareness of the new technology, their participation in clinical trials, organizational support, and how various factors influence their adoption of new technology. Lastly, a database of bare metal and drug eluting stents was examined to document the number of stents used by each physician. Pragmatic and observational findings are presented from the questionnaire, physician profile, to database on stent use. The paper concludes with a discussion of the managerial and forecasting implications and methods to promote technology adoption. © Springer Science + Business Media, Inc. 2006.
引用
收藏
页码：177 / 186
页数：9
相关论文
共 23 条
  • [1] Oleske D., Epidemiology and the Delivery of Health Care Services: Methods and Applications
  • [2] Huckman R.S., Pisano G., Turf battles in coronary revascularization, N. Engl. J. Med., 9, pp. 857-859, (2005)
  • [3] Bhatia V., Bhatia R., Dhindsa M., Drug-eluting stents: New era and new concerns, Postgrad. Med. J., 80, pp. 13-19, (2004)
  • [4] Finarelli Jr., Hugo J., Could your financial health be heading lor heart break? Costly drug-elutmg stents could dramatically alter projected demands for cardiac surgical services, Healthc. Financ. Manage., 57, pp. 68-73, (2003)
  • [5] Kuntz R., Baim D., Defining coronary restenosis: Newer clinical and angiographic paradigms, Circulation, 88, pp. 1310-1323, (1993)
  • [6] Cummings J., Technology Report: Drug Eluting Stents, (2002)
  • [7] Dobesh P.P., Stacy Z.A., Ansara A.J., Enders J.M., Drug-eluting stents: A mechanical and pharmacological approach to coronary artery disease, Pharmacotherapy, 24, pp. 1554-1577, (2004)
  • [8] Van Der Hoeven B., Pires N., Warda H., Oemrawsingh P., Jukema J., Drug Eluting Stents: Results, Promises, and Problems, (2004)
  • [9] Colombo A., Iakovou I., Drug eluting stents: The new gold standard for percutaneous coronary revascularization, Eur. Heart J., 25, 6, (2004)
  • [10] Stanik-Hutt J., Drug-coated stents: Preventing restenosis in coronary artery disease, J. Cardiovasc. Nurs., 19, pp. 404-408, (2004)
123